Eidos Therapeutics
Biotechnology Research · 11 Employees
Phone Number: 6506569920
Email Address: info@eidostx.com
- Overview
- Employees
Access 28 Verified Employees Profiles for Eidos TherapeuticsUnlock Free Contacts Now
About
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company’s singular mission is to improve and prolong the lives of patients suffering from this disease.
Launched in 2016 after years of research supported by Stanford’s SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
Website
Year Founded
2016
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
101 Montgomery St
San Francisco, California, US
Keywords
--
Location
- 101 Montgomery St San Francisco, California, US
Email Formats
Sign up for free credits and discover verified email addresses of Eidos Therapeutics
FormatExamples
first + last
andywarhol@eidostx.com
first_initial + last
awarhol@eidostx.com
first + last_initial
andyw@eidostx.com
first
andy@eidostx.com
last
warhol@eidostx.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Eidos Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.